The peptide Palmitoyl-GHK (Pal-GHK) has garnered considerable attention in the scientific community due to its structural attributes and potential functional roles in biological research and cellular ...

Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.

With every bite of food we take, our intestinal immune system must make a big decision. Tasked with defending us from foreign ...

DelveInsight’s, “Squamous Cell Carcinoma Pipeline Insight” report provides comprehensive insights about 75+ companies and 80+ ...

In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...

LeukemiaANT308 has shown strong single-agent anti-leukemia activity in 2 mouse models.   (2) Pancreatic cancerANT308 has shown synergistic effects with anti-PD-1 checkpoint inhibitors in 3 pancreatic ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Researchers investigate the sex-dependent microglial response to a colony-stimulating factor 1 receptor (CSF1R) inhibitor.